Long-Term Effectiveness and Drug Survival of Secukinumab in Vietnamese Patients with Psoriasis: Results from a Retrospective ENHANCE Study.
Hao Trong NguyenNhi Thi Uyen PhamTu Nguyen Anh TranNguyen Nhat PhamYen Thi BuiThao Thi Phuong VuPublished in: Dermatology and therapy (2022)
Secukinumab demonstrated long-term effectiveness in real-world Vietnamese patients with moderate-to-severe PsO, with treatment adherence being higher in patients having concomitant therapies and national insurance.
Keyphrases
- randomized controlled trial
- end stage renal disease
- systematic review
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prognostic factors
- healthcare
- quality improvement
- high intensity
- health insurance
- patient reported outcomes
- drug induced
- systemic lupus erythematosus
- metabolic syndrome
- skeletal muscle
- combination therapy
- glycemic control